81 related articles for article (PubMed ID: 10908046)
21. Quantification of serotonin transporters in nonhuman primates using [(123)I]ADAM and SPECT.
Acton PD; Choi SR; Hou C; Plössl K; Kung HF
J Nucl Med; 2001 Oct; 42(10):1556-62. PubMed ID: 11585873
[TBL] [Abstract][Full Text] [Related]
22. Striatal 18F-dopa uptake: absence of an aging effect.
Eidelberg D; Takikawa S; Dhawan V; Chaly T; Robeson W; Dahl R; Margouleff D; Moeller JR; Patlak CS; Fahn S
J Cereb Blood Flow Metab; 1993 Sep; 13(5):881-8. PubMed ID: 8360294
[TBL] [Abstract][Full Text] [Related]
23. Loss of metabolites from monkey striatum during PET with FDOPA.
Cumming P; Munk OL; Doudet D
Synapse; 2001 Sep; 41(3):212-8. PubMed ID: 11391782
[TBL] [Abstract][Full Text] [Related]
24. A strategy for removing the bias in the graphical analysis method.
Logan J; Fowler JS; Volkow ND; Ding YS; Wang GJ; Alexoff DL
J Cereb Blood Flow Metab; 2001 Mar; 21(3):307-20. PubMed ID: 11295885
[TBL] [Abstract][Full Text] [Related]
25. Effect of partial volume correction on estimates of the influx and cerebral metabolism of 6-[(18)F]fluoro-L-dopa studied with PET in normal control and Parkinson's disease subjects.
Rousset OG; Deep P; Kuwabara H; Evans AC; Gjedde AH; Cumming P
Synapse; 2000 Aug; 37(2):81-9. PubMed ID: 10881028
[TBL] [Abstract][Full Text] [Related]
26. Cerebral 6-[18F]fluoro-L-DOPA uptake in rhesus monkey: pharmacological influence of aromatic amino acid decarboxylase (AAAD) and catechol-O-methyltransferase (COMT) inhibition.
Psylla M; Günther I; Antonini A; Vontobel P; Reist HW; Zollinger A; Leenders KL
Brain Res; 1997 Aug; 767(1):45-54. PubMed ID: 9365014
[TBL] [Abstract][Full Text] [Related]
27. The influx of neutral amino acids into the porcine brain during development: a positron emission tomography study.
Brust P; Vorwieger G; Walter B; Füchtner F; Stark H; Kuwabara H; Herzau M; Opfermann T; Steinbach J; Ganapathy V; Bauer R
Brain Res Dev Brain Res; 2004 Sep; 152(2):241-53. PubMed ID: 15351512
[TBL] [Abstract][Full Text] [Related]
28. Routes of administration and effect of carbidopa pretreatment on 6-[18F]fluoro-L-dopa/PET scans in non-human primates.
Chan GL; Doudet DJ; Dobko T; Hewitt KA; Schofield P; Pate BD; Ruth TJ
Life Sci; 1995; 56(21):1759-66. PubMed ID: 7739350
[TBL] [Abstract][Full Text] [Related]
29. Quantification of protein synthesis in the human brain using L-[1-11C]-leucine PET: incorporation of factors for large neutral amino acids in plasma and for amino acids recycled from tissue.
Sundaram SK; Muzik O; Chugani DC; Mu F; Mangner TJ; Chugani HT
J Nucl Med; 2006 Nov; 47(11):1787-95. PubMed ID: 17079811
[TBL] [Abstract][Full Text] [Related]
30. A kinetic analysis of 6-[18F]fluoro-L-dihydroxyphenylalanine metabolism in the rat.
Cumming P; Kuwabara H; Gjedde A
J Neurochem; 1994 Nov; 63(5):1675-82. PubMed ID: 7931323
[TBL] [Abstract][Full Text] [Related]
31. In-vivo measurement of LDOPA uptake, dopamine reserve and turnover in the rat brain using [18F]FDOPA PET.
Walker MD; Dinelle K; Kornelsen R; McCormick S; Mah C; Holden JE; Farrer MJ; Stoessl AJ; Sossi V
J Cereb Blood Flow Metab; 2013 Jan; 33(1):59-66. PubMed ID: 22929441
[TBL] [Abstract][Full Text] [Related]
32. FDOPA metabolism in the adult porcine brain: influence of tracer circulation time and VOI selection on estimates of striatal DOPA decarboxylation.
Danielsen EH; Smith DF; Andersen F; Gee AD; Bender D; Hansen SB; Hermansen F; Østergaard L; Cumming P; Gjedde A
J Neurosci Methods; 2001 Oct; 111(2):157-68. PubMed ID: 11595282
[TBL] [Abstract][Full Text] [Related]
33. Modeling and analysis of PET studies with norepinephrine transporter ligands: the search for a reference region.
Logan J; Ding YS; Lin KS; Pareto D; Fowler J; Biegon A
Nucl Med Biol; 2005 Jul; 32(5):531-42. PubMed ID: 15982584
[TBL] [Abstract][Full Text] [Related]
34. Anatomic and biochemical correlates of the dopamine transporter ligand 11C-PE2I in normal and parkinsonian primates: comparison with 6-[18F]fluoro-L-dopa.
Poyot T; Condé F; Grégoire MC; Frouin V; Coulon C; Fuseau C; Hinnen F; Dollé F; Hantraye P; Bottlaender M
J Cereb Blood Flow Metab; 2001 Jul; 21(7):782-92. PubMed ID: 11435790
[TBL] [Abstract][Full Text] [Related]
35. The reproducibility of striatal uptake data obtained with positron emission tomography and fluorine-18-L-6-fluorodopa tracer in non-human primates.
Pate BD; Snow BJ; Hewitt KA; Morrison KS; Ruth TJ; Calne DB
J Nucl Med; 1991 Jun; 32(6):1246-51. PubMed ID: 1904482
[TBL] [Abstract][Full Text] [Related]
36. Modulation of [18F]fluorodopa (FDOPA) kinetics in the brain of healthy volunteers after acute haloperidol challenge.
Vernaleken I; Kumakura Y; Cumming P; Buchholz HG; Siessmeier T; Stoeter P; Müller MJ; Bartenstein P; Gründer G
Neuroimage; 2006 May; 30(4):1332-9. PubMed ID: 16439159
[TBL] [Abstract][Full Text] [Related]
37. 18F-FDOPA PET and PET/CT accurately localize pheochromocytomas.
Imani F; Agopian VG; Auerbach MS; Walter MA; Imani F; Benz MR; Dumont RA; Lai CK; Czernin JG; Yeh MW
J Nucl Med; 2009 Apr; 50(4):513-9. PubMed ID: 19289420
[TBL] [Abstract][Full Text] [Related]
38. PET studies of cerebral levodopa metabolism: a review of clinical findings and modeling approaches.
Kumakura Y; Cumming P
Neuroscientist; 2009 Dec; 15(6):635-50. PubMed ID: 19793723
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of [18F]fluorinated sigma receptor ligands in the conscious monkey brain.
Elsinga PH; Tsukada H; Harada N; Kakiuchi T; Kawamura K; Vaalburg W; Kimura Y; Kobayashi T; Ishiwata K
Synapse; 2004 Apr; 52(1):29-37. PubMed ID: 14755630
[TBL] [Abstract][Full Text] [Related]
40. Effect of catechol-O-methyltransferase inhibition on brain uptake of [18F]fluorodopa: implications for compartmental modelling and clinical usefulness.
Léger G; Gjedde A; Kuwabara H; Guttman M; Cumming P
Synapse; 1998 Dec; 30(4):351-61. PubMed ID: 9826227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
